USFDA19 Jun 2026, 07:30 am
Jubilant Pharmova: USFDA inspects Spokane facility
AI Summary
Jubilant Pharmova Limited announced the conclusion of a USFDA inspection at its subsidiary Jubilant HollisterStier LLC's (JHS) contract manufacturing facility in Spokane, WA. The inspection, which took place on June 17, 2026, resulted in eight observations, none of which were related to sterility assurance concerns. JHS will submit its response to these observations within 15 business days. The company is committed to addressing the observations comprehensively. JHS is a key part of Jubilant Pharmova's sterile injectables and ophthalmics manufacturing capabilities.
Key Highlights
- USFDA inspection of JHS contract manufacturing facility in Spokane completed.
- Eight observations were issued by USFDA.
- No sterility assurance concerns were raised.
- JHS to respond to observations within 15 business days.
Price Impact
More from JUBLPHARMA